What level of Bordetella (B) pertussis copies/ml is considered high and infectious?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 1, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Research

Bordetella pertussis levels above 10,000 copies/ml are generally considered high and highly infectious. Individuals with copy counts in this range are most contagious, especially during the early catarrhal stage of whooping cough (the first 1-2 weeks of illness) 1. Bacterial loads typically peak during this initial phase before the characteristic "whooping" cough develops. The infectiousness decreases significantly after about 5 days of appropriate antibiotic treatment (usually azithromycin, clarithromycin, or erythromycin) 2. Some key points to consider include:

  • The infectious potential correlates with bacterial load but also depends on the patient's symptoms, with those actively coughing expelling more bacteria.
  • Even lower bacterial loads can still be infectious in some circumstances, particularly to unvaccinated individuals or those with compromised immunity.
  • Healthcare providers should implement droplet precautions for patients with suspected or confirmed pertussis infection regardless of the exact bacterial load, and public health authorities typically recommend isolation until completion of 5 days of appropriate antibiotic therapy. It's also worth noting that antibiotic resistance has been reported in some cases, with macrolide-resistant B. pertussis strains isolated from patients in several countries 3. However, the most recent and highest quality study on this topic is not available, and the provided evidence does not specifically address the question of what level of B. pertussis is considered high and infectious. Therefore, the recommendation is based on general knowledge and previous studies, such as 4, which reported on the persistence of B. pertussis in patients despite antibiotic treatment.

Related Questions

What bacterial load of Bordetella (B) pertussis is considered high and potentially infectious?
What is the most appropriate initial antibiotic therapy for a patient with a positive pharyngeal culture for Bordetella, presenting with coughing followed by shortness of breath, and a history of generalized anxiety disorder, hyperlipidemia, and hypertension, who has not had any vaccines in the past 12 years and is currently taking citalopram (Selective Serotonin Reuptake Inhibitor (SSRI)) and pravastatin (HMG-CoA reductase inhibitor)?
How long after starting macrolide (macrolide antibiotic) treatment, such as azithromycin (azithromycin) or clarithromycin (clarithromycin), for pertussis will a nasal swab become negative?
How long is the contagious period for pertussis (whooping cough) infection?
Is laboratory confirmation necessary to start antibiotic treatment for suspected Bordetella (B.) pertussis infection in pediatric patients?
What is the treatment for a stye?
What bacterial load of Bordetella (B) pertussis is considered high and potentially infectious?
What is the recommended treatment for a patient with high-grade ductal carcinoma in situ (DCIS) with a maximal dimension of 3 mm, nuclear grade 3, estrogen receptor (ER) negative, and progesterone receptor (PR) negative, with microcalcifications and necrosis?
What are the management options for Achilles tendinitis?
What is the minimum detectable level of Bordetella (B) pertussis DNA in a nasopharyngeal swab considered indicative of infection?
Is bilateral mastectomy a treatment option for ductal carcinoma in situ (DCIS)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.